sign in
sign in
register
Rules
Sign in with Facebook
Sign in with Linkedin
Remember me
INVESTORS
My Home
Small Cap Marketplace
Broadcast Center
Request New Hub
Quick Tips
Ratings & Ranks
PUBLIC COMPANIES
Investor Relations
Success Stories
Clients
Testimonials
Contact
Conferences
About us
...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
Off topic Forum: Resverlogix Corp.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
NY Times "Most Promising" Updated May 18
imtesty
May 21, 2021 05:41AM
Synairigen News
imtesty
May 21, 2021 05:13AM
One reason for being pulled....
1
CanadianJay
May 14, 2021 11:49AM
Gender differences in responses to BET inhibition
imtesty
Apr 29, 2021 08:32AM
COVID 19 Cardiac Damage - Nature
imtesty
Apr 24, 2021 03:34AM
BET inhibition and breast cancer
imtesty
Apr 13, 2021 06:46AM
BET Inhibition and Skin Ulcers - I KNEW it!!
imtesty
Apr 09, 2021 01:02PM
BET inhibition and Ovarian Cancer
imtesty
Apr 09, 2021 01:53AM
BET inhibition and IBD/colitis (BD1 in this case)
imtesty
Apr 09, 2021 01:52AM
BET inhibition and Sepsis - Repeat so it doesn't get lost
imtesty
Apr 09, 2021 12:32AM
Two more general articles for today
imtesty
Apr 09, 2021 12:28AM
BET inhibition and arthritis
imtesty
Apr 09, 2021 12:17AM
BET inhibition for Dementia and ALS
imtesty
Apr 09, 2021 12:11AM
Combo BET inhibiton & CDK9 inhibition for melanoma
imtesty
Apr 08, 2021 11:59PM
BET inhibition and neuropathic pain
imtesty
Apr 06, 2021 12:38AM
BRD4: An emerging prospective therapeutic target in glioma
imtesty
Apr 02, 2021 04:45AM
Domain-selective targeting of BET proteins in cancer and immunological diseases
imtesty
Apr 02, 2021 04:34AM
Fabrazyme for Fabry
imtesty
Apr 01, 2021 06:17AM
Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT
imtesty
Mar 26, 2021 01:48AM
Donanemab slows cognitive decline in trials
imtesty
Mar 21, 2021 03:12AM
New Message
Log in to Agoracom
Sign in with Facebook
Sign in with Linkedin
Remember me